Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin in Castration Resistant Prostate Cancer. A Multicenter Phase II Trial.

NCT01243385 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT01243385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin in Castration Resistant Prostate Cancer. A Multicenter Phase II Trial.
Lead sponsor
Swiss Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
December 23, 2010
Completion date
August 9, 2019
Enrollment
44 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer